Literature DB >> 6271006

Pathogenetic aspects of hepatitis A virus infection in enterally inoculated marmosets.

K K Krawczynski, D W Bradley, B L Murphy, J W Ebert, T E Anderson, I L Doto, A Nowoslawski, W Duermeyer, J E Maynard.   

Abstract

Experimental hepatitis A virus (HAV) infection was studied in marmosets after enteral (intragastric) inoculation with special reference to the primary sites of HAV replication and immunopathology of the disease. The experiment was carried out using 28 Saguinus mystax negative for antibody to HAV (anti-HAV) and with statistically uniform baseline values of serum isocitrate dehydrogenase (SICD) activity. Each animal was infected with 1 ml of a 15% w/v stool suspension that was derived from marmosets infected with the third or fourth passage of the MS-1 strain of HAV. The incubation period measured by the first significant SICD elevation was 32 days in 11 of 13 marmosets. The animals were sacrificed 2, 4, 7, 11, 14, 18, 23, 28, and 32 days after inoculation and 1, 4, 8, 14, 21, 28, and 35 days after SICD elevation. HAV antigen, immunoglobulins, complement, and fibrin were identified in the liver, eight segments of the gastrointestinal tract, lymphoid system, and kidneys. HAV antigen was found only in the cytoplasm of hepatocytes and in gallbladder bile. These findings indicated that the liver was the sole and primary site of virus replication. Combined immunomorphologic and histopathologic observations also revealed that HAV antigen localization was associated with the sites of hepatocellular damage. There was no immunomorphologic evidence for humoral immune clearance of HAV antigen in the liver, lymphoid system, or kidneys.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271006     DOI: 10.1093/ajcp/76.5.698

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes.

Authors:  C A Blank; D A Anderson; M Beard; S M Lemon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Vectorial entry and release of hepatitis A virus in polarized human hepatocytes.

Authors:  Michelle J Snooks; Purnima Bhat; Jason Mackenzie; Natalie A Counihan; Nicola Vaughan; David A Anderson
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

3.  Progress toward the development of a genetically engineered attenuated hepatitis A virus vaccine.

Authors:  A W Funkhouser; G Raychaudhuri; R H Purcell; S Govindarajan; R Elkins; S U Emerson
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Pathology of hepatitis A infection in the owl monkey (Aotus trivirgatus).

Authors:  C M Keenan; S M Lemon; J W LeDuc; G A McNamee; L N Binn
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

5.  Comparative histology of acute hepatitis B and non-A, non-B in Leuven and Padova.

Authors:  M Rugge; M J Vanstapel; V Ninfo; G Realdi; F Tremolada; P G Montanari; B van Damme; J Fevery; J de Groote; V Desmet
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

6.  The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor.

Authors:  D Feigelstock; P Thompson; P Mattoo; Y Zhang; G G Kaplan
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  Studies on transmission of hepatitis A virus to squirrel monkeys.

Authors:  Cláudia L Vitral; Clara F T Yoshida; Renato S Marchevsky; Marcelo A Pinto; Cristiane S Teixeira; Márcia L Baptista; Ana Maria C Gaspar
Journal:  Primates       Date:  2000-04       Impact factor: 1.781

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.